New weapon tested against deadly recurrent brain tumors
Disease control
Completed
This early-stage study tested a new drug called D2C7-IT in adults whose aggressive brain cancer (malignant glioma) had returned. The main goal was to find the safest dose by delivering the drug directly into the tumor through tiny catheters over 72 hours. Researchers enrolled 81 …
Phase: PHASE1 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC